NO20034187D0 - Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer - Google Patents

Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer

Info

Publication number: NO20034187D0
Authority: NO; Norway
Prior art keywords: spirotric; phosphodiesterase; inhibitors; novel; cyclic derivatives
Prior art date: 2001-03-21

Application number

NO20034187A

Other languages

English (en)

Other versions

NO326086B1 (no

NO20034187L (no

Inventor

Patrick Bernardelli

Pierre Ducrot

Edwige Lorthiois

Fabrice Vergne

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-21

Filing date

2003-09-19

Publication date

2003-09-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8164349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20034187(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-09-19 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2003-09-19 Publication of NO20034187D0 publication Critical patent/NO20034187D0/no

2003-10-15 Publication of NO20034187L publication Critical patent/NO20034187L/no

2008-09-15 Publication of NO326086B1 publication Critical patent/NO326086B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO20034187A 2001-03-21 2003-09-19 Nye spirotricykliske derivater, anvendelse og fremstilling derav samt farmasoytisk preparat NO326086B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/EP2001/003355 WO2002076953A1 (en)	2001-03-21	2001-03-21	New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
PCT/EP2002/003594 WO2002074754A1 (en)	2001-03-21	2002-03-18	New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors

Publications (3)

Publication Number	Publication Date
NO20034187D0 true NO20034187D0 (no)	2003-09-19
NO20034187L NO20034187L (no)	2003-10-15
NO326086B1 NO326086B1 (no)	2008-09-15

Family

ID=8164349

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034187A NO326086B1 (no)	2001-03-21	2003-09-19	Nye spirotricykliske derivater, anvendelse og fremstilling derav samt farmasoytisk preparat

Country Status (47)

Country	Link
US (3)	US20020198198A1 (no)
EP (2)	EP1373224B1 (no)
JP (1)	JP4086663B2 (no)
KR (1)	KR100617435B1 (no)
CN (1)	CN100447136C (no)
AP (1)	AP1699A (no)
AR (1)	AR033617A1 (no)
AT (1)	ATE367381T1 (no)
AU (1)	AU2002304800B2 (no)
BG (1)	BG108181A (no)
BR (1)	BR0208192A (no)
CA (1)	CA2441313C (no)
CU (1)	CU23218A3 (no)
CY (1)	CY1106829T1 (no)
CZ (1)	CZ20032451A3 (no)
DE (1)	DE60221233T2 (no)
DK (1)	DK1373224T3 (no)
EA (1)	EA006815B1 (no)
EC (1)	ECSP034750A (no)
EE (1)	EE200300459A (no)
ES (1)	ES2288552T3 (no)
GE (1)	GEP20053631B (no)
GT (1)	GT200200053A (no)
HK (1)	HK1061854A1 (no)
HR (1)	HRP20030740A2 (no)
HU (1)	HUP0303637A3 (no)
IL (2)	IL157659A0 (no)
IS (1)	IS2529B (no)
MA (1)	MA27001A1 (no)
MX (1)	MXPA03008485A (no)
MY (1)	MY142045A (no)
NO (1)	NO326086B1 (no)
NZ (1)	NZ527847A (no)
OA (1)	OA12454A (no)
PA (1)	PA8541601A1 (no)
PE (1)	PE20021010A1 (no)
PL (1)	PL367058A1 (no)
PT (1)	PT1373224E (no)
RS (1)	RS50429B (no)
SI (1)	SI1373224T1 (no)
SK (1)	SK11562003A3 (no)
SV (1)	SV2003000925A (no)
TN (1)	TNSN03076A1 (no)
TW (1)	TWI267509B (no)
UA (1)	UA74243C2 (no)
WO (2)	WO2002076953A1 (no)
ZA (1)	ZA200306601B (no)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1400244A1 (en) *	2002-09-17	2004-03-24	Warner-Lambert Company LLC	New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
GB0230195D0 (en) *	2002-12-24	2003-02-05	Biofocus Plc	Compound Libraries
WO2004096139A2 (en)	2003-04-24	2004-11-11	Incyte Corporation	Aza spiro alkane derivatives as inhibitors of metalloproteases
JP2006219374A (ja)	2003-06-13	2006-08-24	Daiichi Asubio Pharma Co Ltd	Ｐｄｅ７阻害作用を有するイミダゾトリアジノン誘導体
JP2006219373A (ja)	2003-06-13	2006-08-24	Daiichi Asubio Pharma Co Ltd	Ｐｄｅ７阻害作用を有するピリジニルピラゾロピリミジノン誘導体
WO2005013997A1 (en) *	2003-08-12	2005-02-17	F. Hoffmann-La Roche Ag	Spiro-substituted tetrahydroquinazolines as corticotropin releasing factor (cfr) antagonists
CA2569530C (en)	2004-07-01	2013-07-30	Daiichi Asubio Pharma Co.,Ltd.	Thienopyrazole derivative having pde 7 inhibitory activity
GB0504209D0 (en) *	2005-03-01	2005-04-06	Pfizer Ltd	New use of PDE7 inhibitors
WO2006092692A1 (en) *	2005-03-01	2006-09-08	Pfizer Limited	Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
US20090111837A1 (en) *	2005-03-01	2009-04-30	Peter Cox	Use of pde7 inhibitors for the treatment of neuropathic pain
KR100680497B1 (ko) *	2005-07-25	2007-02-08	엘지전자 주식회사	근거리통신 시스템에서 단말기가 액세스 포인트에 접속하는방법
EP2258358A3 (en)	2005-08-26	2011-09-07	Braincells, Inc.	Neurogenesis with acetylcholinesterase inhibitor
JP2009506069A (ja)	2005-08-26	2009-02-12	ブレインセルス，インコーポレイティド	ムスカリン性受容体調節による神経発生
WO2007047978A2 (en)	2005-10-21	2007-04-26	Braincells, Inc.	Modulation of neurogenesis by pde inhibition
WO2007053596A1 (en)	2005-10-31	2007-05-10	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
NZ568694A (en)	2005-11-09	2011-09-30	Zalicus Inc	Method, compositions, and kits for the treatment of medical conditions
BRPI0619126A2 (pt)	2005-12-02	2011-09-13	Pfizer Ltd	derivados espirocìclicos, composição farmacêutica e usos dos mesmos
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
CA2651862A1 (en)	2006-05-09	2007-11-22	Braincells, Inc.	5 ht receptor mediated neurogenesis
EP2382975A3 (en)	2006-05-09	2012-02-29	Braincells, Inc.	Neurogenesis by modulating angiotensin
KR20090064418A (ko) *	2006-09-08	2009-06-18	브레인셀즈 인코퍼레이션	4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
US8637528B2 (en)	2007-03-27	2014-01-28	Omeros Corporation	Use of PDE7 inhibitors for the treatment of movement disorders
ES2533206T3 (es) *	2007-03-27	2015-04-08	Omeros Corporation	Inhibidores de PDE7 para uso en el tratamiento de trastornos del movimiento
CA2687944A1 (en) *	2007-05-24	2008-11-27	Pfizer Limited	Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
US20100216805A1 (en)	2009-02-25	2010-08-26	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
KR20130124333A (ko)	2010-11-08	2013-11-13	오메로스 코포레이션	Pde7 억제제를 사용한 중독 및 충동-조절 장애의 치료
US9220715B2 (en)	2010-11-08	2015-12-29	Omeros Corporation	Treatment of addiction and impulse-control disorders using PDE7 inhibitors
US8754114B2 (en)	2010-12-22	2014-06-17	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
WO2013106547A1 (en)	2012-01-10	2013-07-18	President And Fellows Of Harvard College	Beta-cell replication promoting compounds and methods of their use
DK3176170T3 (en)	2012-06-13	2019-01-28	Incyte Holdings Corp	SUBSTITUTED TRICYCLIC RELATIONS AS FGFR INHIBITORS
US9388185B2 (en)	2012-08-10	2016-07-12	Incyte Holdings Corporation	Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
CA3130452C (en)	2013-04-19	2023-10-31	Incyte Holdings Corporation	Bicyclic heterocycles as fgfr inhibitors
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
MX373169B (es)	2015-02-20	2020-04-24	Incyte Holdings Corp	Heterociclos bicíclicos como inhibidores de receptores del factor de crecimiento fibroblástico (fgfr).
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
US9580423B2 (en)	2015-02-20	2017-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
AU2016369835B2 (en) *	2015-12-16	2020-10-15	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Pyrido[1,2-a]pyrimidone analog, crystal form thereof, intermediate thereof and preparation method therefor
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
CN107382976A (zh) *	2017-07-04	2017-11-24	孙秀芹	一种治疗盆腔炎的化合物及制备方法和应用
KR102640696B1 (ko) *	2017-07-12	2024-02-27	다트 뉴로사이언스, 엘엘씨	Pde7 억제제로서 치환된 벤즈옥사졸 및 벤조푸란 화합물
CN112867716B (zh)	2018-05-04	2024-09-13	因赛特公司	Fgfr抑制剂的固体形式和其制备方法
AU2019262579B2 (en)	2018-05-04	2024-09-12	Incyte Corporation	Salts of an FGFR inhibitor
US11628162B2 (en)	2019-03-08	2023-04-18	Incyte Corporation	Methods of treating cancer with an FGFR inhibitor
WO2021007269A1 (en)	2019-07-09	2021-01-14	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
US12122767B2 (en)	2019-10-01	2024-10-22	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
PH12022550892A1 (en)	2019-10-14	2023-05-03	Incyte Corp	Bicyclic heterocycles as fgfr inhibitors
US11566028B2 (en)	2019-10-16	2023-01-31	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
CA3163875A1 (en)	2019-12-04	2021-06-10	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
CA3162010A1 (en)	2019-12-04	2021-06-10	Incyte Corporation	Derivatives of an fgfr inhibitor
WO2021146424A1 (en)	2020-01-15	2021-07-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
JP2024513575A (ja)	2021-04-12	2024-03-26	インサイト・コーポレイション	Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法
AR126102A1 (es)	2021-06-09	2023-09-13	Incyte Corp	Heterociclos tricíclicos como inhibidores de fgfr
IL318817A (en)	2022-08-18	2025-04-01	Mitodicure Gmbh	Use of a therapeutic agent with PHOSPHODIESTERASE-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exercise intolerance

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5815979A (ja)	1981-07-11	1983-01-29	Kyowa Hakko Kogyo Co Ltd	新規なピペリジン誘導体およびその製造法
US4764512A (en)	1986-08-27	1988-08-16	Rorer Pharmaceutical Corporation	Benzodiazinone-pyridone compounds, cardiotonic compositions including the same, and their uses
GR1000821B (el) *	1988-11-22	1993-01-25	Tanabe Seiyaku Co	Μεθοδος παραγωγης παραγωγων κιναζολινονης.
US5536716A (en)	1992-12-11	1996-07-16	Merck & Co., Inc.	Spiro piperidines and homologs which promote release of growth hormone
CZ151495A3 (en)	1992-12-11	1995-12-13	Merck & Co Inc	Spiropiperidine derivatives, process of their preparation and a pharmaceutical composition containing thereof
US5602143A (en) *	1994-12-08	1997-02-11	Allergan	Method for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitors
AU704133B2 (en) *	1995-10-17	1999-04-15	Astrazeneca Ab	Pharmaceutically active quinazoline compounds
CN1205008A (zh) *	1996-08-30	1999-01-13	协和发酵工业株式会社	咪唑并喹唑啉衍生物
WO2000066560A1 (en) *	1999-05-04	2000-11-09	American Home Products Corporation	Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6358948B1 (en)	1999-05-04	2002-03-19	American Home Products Corporation	Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6498154B1 (en)	1999-05-04	2002-12-24	Wyeth	Cyclic regimens using quinazolinone and benzoxazine derivatives
DE60013798T2 (de)	1999-05-04	2005-09-29	Wyeth	Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten
US6509334B1 (en)	1999-05-04	2003-01-21	American Home Products Corporation	Cyclocarbamate derivatives as progesterone receptor modulators
AU2274101A (en)	1999-12-21	2001-07-03	Merck & Co., Inc.	Inhibitors of prenyl-protein transferase
UA73119C2 (en)	2000-04-19	2005-06-15	American Home Products Corpoir	Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors

2001
- 2001-03-21 AP APAP/P/2003/002857A patent/AP1699A/en active
- 2001-03-21 WO PCT/EP2001/003355 patent/WO2002076953A1/en active Application Filing
2002
- 2002-03-05 TW TW091104028A patent/TWI267509B/zh not_active IP Right Cessation
- 2002-03-18 EE EEP200300459A patent/EE200300459A/xx unknown
- 2002-03-18 RS YUP-740/03A patent/RS50429B/sr unknown
- 2002-03-18 PT PT02732544T patent/PT1373224E/pt unknown
- 2002-03-18 AT AT02732544T patent/ATE367381T1/de not_active IP Right Cessation
- 2002-03-18 CZ CZ20032451A patent/CZ20032451A3/cs unknown
- 2002-03-18 UA UA2003098601A patent/UA74243C2/uk unknown
- 2002-03-18 IL IL15765902A patent/IL157659A0/xx active IP Right Grant
- 2002-03-18 CN CNB028069714A patent/CN100447136C/zh not_active Expired - Fee Related
- 2002-03-18 KR KR1020037012247A patent/KR100617435B1/ko not_active Expired - Fee Related
- 2002-03-18 WO PCT/EP2002/003594 patent/WO2002074754A1/en active Application Filing
- 2002-03-18 EP EP02732544A patent/EP1373224B1/en not_active Expired - Lifetime
- 2002-03-18 MX MXPA03008485A patent/MXPA03008485A/es active IP Right Grant
- 2002-03-18 MY MYPI20020954A patent/MY142045A/en unknown
- 2002-03-18 SK SK1156-2003A patent/SK11562003A3/sk not_active Application Discontinuation
- 2002-03-18 GE GE5294A patent/GEP20053631B/en unknown
- 2002-03-18 DK DK02732544T patent/DK1373224T3/da active
- 2002-03-18 ES ES02732544T patent/ES2288552T3/es not_active Expired - Lifetime
- 2002-03-18 OA OA1200300226A patent/OA12454A/en unknown
- 2002-03-18 BR BR0208192-0A patent/BR0208192A/pt not_active IP Right Cessation
- 2002-03-18 JP JP2002573763A patent/JP4086663B2/ja not_active Expired - Fee Related
- 2002-03-18 NZ NZ527847A patent/NZ527847A/en unknown
- 2002-03-18 CA CA002441313A patent/CA2441313C/en not_active Expired - Fee Related
- 2002-03-18 SI SI200230587T patent/SI1373224T1/sl unknown
- 2002-03-18 EP EP07104642A patent/EP1801106A3/en not_active Withdrawn
- 2002-03-18 AU AU2002304800A patent/AU2002304800B2/en not_active Ceased
- 2002-03-18 TN TNPCT/EP2002/003594A patent/TNSN03076A1/en unknown
- 2002-03-18 DE DE60221233T patent/DE60221233T2/de not_active Expired - Lifetime
- 2002-03-18 HU HU0303637A patent/HUP0303637A3/hu unknown
- 2002-03-18 PL PL02367058A patent/PL367058A1/xx not_active Application Discontinuation
- 2002-03-18 EA EA200300906A patent/EA006815B1/ru unknown
- 2002-03-19 US US10/101,996 patent/US20020198198A1/en not_active Abandoned
- 2002-03-20 GT GT200200053A patent/GT200200053A/es unknown
- 2002-03-20 AR ARP020100993A patent/AR033617A1/es active IP Right Grant
- 2002-03-20 PA PA20028541601A patent/PA8541601A1/es unknown
- 2002-03-20 PE PE2002000212A patent/PE20021010A1/es not_active Application Discontinuation
- 2002-03-20 SV SV2002000925A patent/SV2003000925A/es not_active Application Discontinuation
2003
- 2003-08-25 ZA ZA200306601A patent/ZA200306601B/en unknown
- 2003-08-27 EC EC2003004750A patent/ECSP034750A/es unknown
- 2003-08-28 IL IL157659A patent/IL157659A/en not_active IP Right Cessation
- 2003-08-29 CU CU20030188A patent/CU23218A3/es not_active IP Right Cessation
- 2003-08-29 IS IS6934A patent/IS2529B/is unknown
- 2003-09-12 MA MA27310A patent/MA27001A1/fr unknown
- 2003-09-15 HR HR20030740A patent/HRP20030740A2/hr not_active Application Discontinuation
- 2003-09-17 BG BG108181A patent/BG108181A/xx active Pending
- 2003-09-19 NO NO20034187A patent/NO326086B1/no not_active IP Right Cessation
2004
- 2004-05-24 US US10/852,404 patent/US7214676B2/en not_active Expired - Fee Related
- 2004-07-06 HK HK04104855.2A patent/HK1061854A1/xx not_active IP Right Cessation
2006
- 2006-10-20 US US11/551,687 patent/US20070049558A1/en not_active Abandoned
2007
- 2007-08-30 CY CY20071101121T patent/CY1106829T1/el unknown

Also Published As

Publication number	Publication date
WO2002074754A1 (en)	2002-09-26
AR033617A1 (es)	2003-12-26
UA74243C2 (uk)	2005-11-15
YU74003A (sh)	2006-05-25
HUP0303637A3 (en)	2004-07-28
CY1106829T1 (el)	2012-05-23
PE20021010A1 (es)	2003-02-01
AP1699A (en)	2006-12-26
EE200300459A (et)	2004-02-16
SV2003000925A (es)	2003-05-20
CA2441313C (en)	2009-03-31
EA006815B1 (ru)	2006-04-28
ES2288552T3 (es)	2008-01-16
US20070049558A1 (en)	2007-03-01
TWI267509B (en)	2006-12-01
EP1373224A1 (en)	2004-01-02
EP1801106A3 (en)	2007-07-04
AP2003002857A0 (en)	2003-09-30
JP2004529123A (ja)	2004-09-24
CU23218A3 (es)	2007-07-20
MXPA03008485A (es)	2003-12-08
SI1373224T1 (sl)	2007-10-31
DE60221233T2 (de)	2008-04-03
KR100617435B1 (ko)	2006-08-31
DK1373224T3 (da)	2007-10-15
WO2002076953A1 (en)	2002-10-03
EP1801106A2 (en)	2007-06-27
GT200200053A (es)	2003-02-12
PA8541601A1 (es)	2003-05-14
US20040214843A1 (en)	2004-10-28
EP1373224B1 (en)	2007-07-18
IL157659A (en)	2008-08-07
PT1373224E (pt)	2007-09-25
CN100447136C (zh)	2008-12-31
EA200300906A1 (ru)	2004-02-26
GEP20053631B (en)	2005-10-10
TNSN03076A1 (en)	2005-12-23
RS50429B (sr)	2009-12-31
ATE367381T1 (de)	2007-08-15
CA2441313A1 (en)	2002-09-26
US7214676B2 (en)	2007-05-08
KR20030086315A (ko)	2003-11-07
BR0208192A (pt)	2004-03-02
ECSP034750A (es)	2003-10-28
IS2529B (is)	2009-07-15
PL367058A1 (en)	2005-02-21
OA12454A (en)	2004-09-30
BG108181A (en)	2004-09-30
NO326086B1 (no)	2008-09-15
NZ527847A (en)	2005-06-24
US20020198198A1 (en)	2002-12-26
MY142045A (en)	2010-08-30
DE60221233D1 (de)	2007-08-30
IS6934A (is)	2003-08-29
HK1061854A1 (en)	2004-10-08
MA27001A1 (fr)	2004-12-20
CZ20032451A3 (cs)	2004-09-15
NO20034187L (no)	2003-10-15
ZA200306601B (en)	2004-08-25
SK11562003A3 (sk)	2005-01-03
IL157659A0 (en)	2004-03-28
JP4086663B2 (ja)	2008-05-14
HUP0303637A2 (hu)	2004-03-01
CN1498212A (zh)	2004-05-19
HRP20030740A2 (en)	2005-06-30
AU2002304800B2 (en)	2007-08-30

Publication	Publication Date	Title
NO20034187D0 (no)	2003-09-19	Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer
DK2305250T3 (da)	2014-04-22	Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer
NO20034308L (no)	2003-11-26	Nye tyrokinase-inhibitorer
NO20030301D0 (no)	2003-01-20	Nye heteroarylderivater og anvendelse derav som farmasöytika
DK1499311T3 (da)	2010-03-08	Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer
NO20053356D0 (no)	2005-07-11	Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
DK1564210T5 (da)	2010-05-03	4-Oxoquinolinforbindelser og anvendelse deraf som HIV-integraseinhibitorer
NO20032465L (no)	2003-07-25	Nye mandelsyre-derivater og anvendelse derav som trombininhibitorer
NO20030302D0 (no)	2003-01-20	Nye heteroarylderivater og deres anvendelse som medikamenter
NO20030298D0 (no)	2003-01-20	Nye heteroarylderivater og deres anvendelse som farmasöytiske midler
DK1527050T3 (da)	2010-07-19	Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer
DK1501815T3 (da)	2007-04-02	Substituerede phenylacetamider og anvendelse deraf som glucokinaseaktivatorer
NO20050830L (no)	2005-02-16	Acylerte heteroarylkondenserte sykloalkenylaminer og deres anvendelse som farmasoytiske midler
NO20032830L (no)	2003-08-04	Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer
NO20034970D0 (no)	2003-11-07	Nye arylheteroalkylaminderivater
NO20042719L (no)	2004-06-28	Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer
NO20031482D0 (no)	2003-04-01	Nye tiadiazoler og oksadiazoler, og anvendelse derav som fosfodiesterase-7inhibitorer
DK1581518T3 (da)	2011-06-06	Substituerede 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazin-derivater og deres anvendelse som neurokinin antagonister
DK1429769T3 (da)	2009-05-11	Nye formuleringer og anvendelse deraf
NO20040996L (no)	2004-05-12	Nye forbindelser og sammensetninger som catepsin-inhibitorer
NO20035328D0 (no)	2003-11-28	Nye forbindelser og preparater som katepsinhibitorer
DK1150996T3 (da)	2008-02-11	Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer
DK1387838T3 (da)	2006-08-14	Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
NO20025504L (no)	2002-11-15	Nye tiokromanderivater og anvendelse derav som trombininhibitorer
NO20052124D0 (no)	2005-04-29	Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse

Legal Events

Date	Code	Title	Description
2012-10-22	MM1K	Lapsed by not paying the annual fees